As of Feb 24th, 2025, there has been substantial selling of Inhibikase Therapeutics, Inc. in recent trading

The chart below shows ALL of the short selling each day in INHIBIKASE THERAPEUTICS, INC. (IKT). We have consolidated the tape of ALL US stock exchanges and dark pools (this means we get the TRADE IDENTIFIER showing whether the trade was a buy, sell or sell short). The data below shows just the short sales each day in your stock. It includes both EXEMPT (market makers) and NON-EXEMPT (everyone else) short sales in INHIBIKASE THERAPEUTICS, INC.. An average of 39.61% of the daily trading in IKT is short selling. This is abnormally high and implies there is illicit trading taking place in your stock. We run automated surveillance and reporting algorithms that report manipulative market making and short selling (to FINRA, SEC, Whistleblower's Office and Dept of Treasury FINCEN). We then issue FINRA COMPLIANT research to our large user base to counteract this activity that is driving IKT lower unfairly.

You can find the full report at [ https://www.woprai.com/ ]

Please find the applicable data below, drawn from all major market providers.

Date	Short Volume	Total Volume	Percentage	Squeeze Trigger	$ Value
2025-02-21	89,842	266,628	33.7	3.1	278,510
2025-02-20	104,751	282,832	37.04	3.18	333,108
2025-02-19	121,175	258,856	46.81	2.84	344,137
2025-02-18	118,715	227,951	52.08	2.49	295,600
2025-02-14	62,098	121,357	51.17	2.32	144,067
2025-02-13	54,980	90,659	60.64	2.25	123,705
2025-02-12	75,449	139,262	54.18	2.31	174,287
2025-02-11	88,324	156,100	56.58	2.38	210,211
2025-02-10	137,242	256,697	53.46	2.42	332,126
2025-02-07	85,419	154,401	55.32	2.39	204,151
2025-02-06	107,033	239,541	44.68	2.45	262,231
2025-02-05	61,934	156,982	39.45	2.28	141,210
2025-02-04	60,502	159,231	38	2.17	131,289
2025-02-03	125,019	227,674	54.91	2.14	267,541
2025-01-31	201,942	439,249	45.97	2.14	432,156
2025-01-30	437,406	982,345	44.53	2.11	922,927
2025-01-29	62,017	96,838	64.04	2.79	173,027
2025-01-28	56,532	81,908	69.02	2.73	154,332
2025-01-27	41,972	84,204	49.85	2.76	115,843
2025-01-24	51,459	80,767	63.71	2.81	144,600
2025-01-23	60,618	119,298	50.81	2.83	171,549
2025-01-22	47,463	79,658	59.58	2.78	131,947
2025-01-21	73,995	125,680	58.88	2.78	205,706
2025-01-17	26,020	39,566	65.76	2.76	71,815
2025-01-16	60,502	92,417	65.47	2.73	165,170
2025-01-15	55,072	82,847	66.47	2.74	150,897
2025-01-14	57,583	86,646	66.46	2.73	157,202
2025-01-13	70,262	146,777	47.87	2.79	196,031
2025-01-10	85,110	178,433	47.7	2.98	253,628
2025-01-08	53,623	101,852	52.65	3.2	171,594
2025-01-07	79,940	190,718	41.92	3.21	256,607
2025-01-06	135,960	301,750	45.06	3.22	437,791
2025-01-03	116,725	188,119	62.05	3.24	378,189
2025-01-02	41,761	81,342	51.34	3.28	136,976
2024-12-31	119,111	200,877	59.3	3.25	387,111
2024-12-30	71,603	131,551	54.43	3.11	222,685
2024-12-27	29,625	58,502	50.64	3.01	89,171

Total	95,851,893	241,776,817	39.64	1.94	186,302,551

* Totals include all data records back to 2020-12-28 00:00:00, data set is truncated for viewing.

Contributing Sources

WOPRAI

support@woprai.com
www.woprai.com

N@N

As of Feb 24th, 2025, there has been substantial selling of Inhibikase Therapeutics, Inc. in recent trading